Royalty Pharma (RPRX) Stock Receives ‘Buy’ Rating from Goldman Sachs
Goldman Sachs likes Royalty Pharma with 'buy' rating as with investors money in Royalty Pharma (RPRX) is leading the charge with its investors betting big money on its success as…
Goldman Sachs likes Royalty Pharma with 'buy' rating as with investors money in Royalty Pharma (RPRX) is leading the charge with its investors betting big money on its success as…
Bittrex cryptocurrency exchange goes bankrupt as 2nd largest platform after FTX In a stunning turn of events, Bittrex - the second largest cryptocurrency exchange platform after FTX - has filed…
Stocks drop on debt ceiling talks and poor retail sales data from wall street Today was not a great day as we see stocks drop as talks on raising the…
Vice files for bankruptcy amid digital media industry trouble of costs and value The news of Vice Media filing for bankruptcy on Monday sent shockwaves through the media industry, as…
Tesla stock pops after Elon Musk picks new Twitter CEO and move to CTO & product Friday was a very exciting day for Tesla stock, as the company's share price…
Paramount Global stock drops with missed earnings on steaming decline and ads loss Paramount Global (PARA) were under pressure this week after the release of their latest earnings report which…
Strong tech stock reaction like META to recent economic data The markets saw a positive day of trading today in response to the release of lower than expected economic data.…
How the Commodity Exchange Act (CEA) impacts today's stock investors In today’s volatile stock market, investors must be aware of all the regulations and laws that can impact their trading…